News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
252,546 Results
Type
Article (5901)
Company Profile (28)
Press Release (246617)
Multimedia
Podcasts (2)
Webinars (5)
Section
Business (87679)
Career Advice (472)
Deals (16484)
Drug Delivery (9)
Drug Development (21245)
Employer Resources (32)
FDA (4054)
Job Trends (4556)
News (129787)
Policy (8423)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (337)
Accelerated approval (8)
Adcomms (4)
Allergies (15)
Alliances (16226)
ALS (42)
Alzheimer's disease (378)
Antibody-drug conjugate (ADC) (48)
Approvals (4165)
Artificial intelligence (95)
Autoimmune disease (32)
Automation (5)
Bankruptcy (107)
Best Places to Work (3390)
Biosimilars (33)
Biotechnology (30)
Bladder cancer (39)
Brain cancer (10)
Breast cancer (144)
Cancer (1025)
Cardiovascular disease (68)
Career advice (404)
Career pathing (3)
CAR-T (67)
CDC (2)
Cell therapy (179)
Cervical cancer (5)
Clinical research (18518)
Collaboration (394)
Compensation (383)
Complete response letters (9)
COVID-19 (461)
CRISPR (13)
C-suite (358)
Cystic fibrosis (30)
Data (1476)
Denatured (1)
Depression (24)
Diabetes (90)
Diagnostics (2337)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (48)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (38)
Earnings (44773)
Editorial (5)
Employer branding (6)
Employer resources (34)
Events (41987)
Executive appointments (449)
FDA (4848)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (400)
Gene editing (25)
Generative AI (5)
Gene therapy (102)
GLP-1 (164)
Government (519)
Guidances (203)
Healthcare (5577)
HIV (10)
Huntington's disease (5)
IgA nephropathy (18)
Immunology and inflammation (41)
Immuno-oncology (8)
Indications (16)
Infectious disease (493)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (37)
Interviews (57)
IPO (8473)
IRA (3)
Job creations (1259)
Job search strategy (366)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (113)
Leadership (5)
Legal (2679)
Liver cancer (21)
Longevity (4)
Lung cancer (105)
Lymphoma (75)
Machine learning (4)
Management (11)
Manufacturing (155)
MASH (50)
Medical device (4368)
Medtech (4381)
Mergers & acquisitions (8475)
Metabolic disorders (230)
Multiple sclerosis (22)
NASH (6)
Neurodegenerative disease (65)
Neuropsychiatric disorders (14)
Neuroscience (654)
NextGen: Class of 2026 (1792)
Non-profit (793)
Now hiring (5)
Obesity (89)
Opinion (33)
Ovarian cancer (26)
Pain (33)
Pancreatic cancer (51)
Parkinson's disease (52)
Partnered (12)
Patents (67)
Patient recruitment (105)
Peanut (6)
People (27120)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase 1 (5506)
Phase 2 (8139)
Phase 3 (6396)
Pipeline (2046)
Policy (17)
Postmarket research (658)
Preclinical (2176)
Press Release (67)
Prostate cancer (63)
Psychedelics (5)
Radiopharmaceuticals (126)
Rare diseases (189)
Real estate (2025)
Recruiting (9)
Regulatory (6097)
Reports (18)
Research institute (359)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (4)
RSV (2)
Schizophrenia (57)
Series A (58)
Series B (56)
Service/supplier (2)
Sickle cell disease (11)
Special edition (1)
Spinal muscular atrophy (35)
Sponsored (6)
Startups (1132)
State (1)
Stomach cancer (1)
Supply chain (17)
Tariffs (7)
The Weekly (1)
Vaccines (107)
Venture capital (10)
Weight loss (30)
Women's health (7)
Date
Last 7 days (169)
Last 30 days (633)
Last 365 days (9911)
2026 (879)
2025 (10088)
2024 (12205)
2023 (14506)
2022 (20418)
2021 (21838)
2020 (19697)
2019 (14289)
2018 (10999)
2017 (10865)
2016 (9993)
2015 (13151)
2014 (10359)
2013 (8347)
2012 (9039)
2011 (9442)
2010 (9255)
Location
Africa (201)
Alabama (20)
Alaska (2)
Arizona (83)
Arkansas (1)
Asia (12514)
Australia (1760)
California (3670)
Canada (1766)
China (173)
Colorado (152)
Connecticut (168)
Delaware (76)
Europe (26902)
Florida (564)
Georgia (76)
Idaho (24)
Illinois (168)
India (15)
Indiana (139)
Iowa (9)
Japan (178)
Kansas (37)
Kentucky (18)
Louisiana (8)
Maine (51)
Maryland (359)
Massachusetts (2915)
Michigan (143)
Minnesota (231)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (14)
Nevada (53)
New Hampshire (27)
New Jersey (1230)
New Mexico (8)
New York (924)
North Carolina (517)
North Dakota (4)
Northern California (1915)
Ohio (117)
Oklahoma (8)
Oregon (6)
Pennsylvania (687)
Puerto Rico (2)
Rhode Island (19)
South America (311)
South Carolina (17)
Southern California (1344)
Tennessee (71)
Texas (561)
United States (13328)
Utah (114)
Virginia (85)
Washington D.C. (17)
Washington State (307)
West Virginia (2)
Wisconsin (71)
Wyoming (2)
252,546 Results for "sernova corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts
November 13, 2025
·
4 min read
Press Releases
Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang
October 1, 2025
·
5 min read
Press Releases
Chair of Sernova Biotherapeutics Resigns
May 26, 2025
·
1 min read
Press Releases
Sernova Appoints Jonathan Rigby as Interim Chair
June 3, 2025
·
3 min read
Press Releases
Sernova Corp. Announces Appointment of New Chief Executive Officer
August 12, 2024
·
5 min read
Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes
Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company, today announces developments in its Phase I/II clinical trial investigating a novel treatment for Type 1 Diabetes (T1D). To date a total of 7 patients across Cohorts 1 and 2 have achieved insulin independence following transplants of human donor islets via Sernova’s proprietary Cell Pouch System™ and a marginal portal vein top up.
June 25, 2024
·
6 min read
Press Releases
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
January 30, 2025
·
4 min read
Business
Concerned Shareholders of Sernova Corp. Nominate Two Highly Qualified Directors to the Board
A group of longstanding shareholders of Sernova Corp who currently own approximately 12% of the Company’s shares have concerns regarding the performance of Sernova’s Board.
April 3, 2023
·
9 min read
Press Releases
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
July 10, 2025
·
5 min read
Press Releases
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
·
5 min read
1 of 25,255
Next
